Direct Oral Anticoagulants versus Vitamin K Antagonists for Left Ventricular Thrombus: A Meta-Analysis with Trial Sequential Analysis.
Eric PasqualottoDouglas Mesadri GewehrRafael Oliva Morgado FerreiraMatheus Pedrotti ChavezCaroliny Hellen SilvaSara Almeida CruzJhonny Limachi-ChoqueAmanda ParkMário Sérgio Soares de Azeredo CoutinhoLuiz Fernando KubruslyPublished in: Arquivos brasileiros de cardiologia (2024)
DOACs had a similar rate of thromboembolic and hemorrhagic events, as well as thrombus resolution, compared to VKAs in the treatment of LVTs. Rivaroxaban therapy had a significant reduction in thromboembolic events, compared to VKAs.
Keyphrases
- direct oral anticoagulants
- atrial fibrillation
- venous thromboembolism
- left ventricular
- left atrial
- heart failure
- catheter ablation
- clinical trial
- percutaneous coronary intervention
- study protocol
- acute myocardial infarction
- phase iii
- pulmonary embolism
- hypertrophic cardiomyopathy
- single molecule
- mitral valve
- cardiac resynchronization therapy
- replacement therapy